Infectious Diseases
Opinion
Wave, surge, or tsunami
Predictive models for COVID-19 have strengths and weaknesses and none are perfect.
Conference Coverage
Hep C sofosbuvir/daclatasvir combo promising for COVID-19
“We need to remember that conducting research amidst a pandemic with overwhelmed hospitals is a clear challenge, and we cannot be sure of success...
Latest News
Hyperglycemia predicts COVID-19 death even without diabetes
This finding came from a retrospective analysis of 605 patients with COVID-19 seen at two hospitals in Wuhan, China.
News
Children rarely transmit SARS-CoV-2 within households
Most children with COVID-19 disease are infected inside family groups, but are not the initial transmitters.
Opinion
‘Doc, can I get a mask exemption?’
"It makes sense to say that if it makes you uncomfortable to wear a mask because it affects your breathing, you should think twice about getting...
Conference Coverage
Neural tube defect risk from dolutegravir drops as clinical experience grows
A troubling link between the top HIV drug dolutegravir and neural tube defects, first reported in 2018, now seems much less dangerous.
News
FDA OKs first-in-class HIV therapy for patients with few options
“The availability of new classes of antiretroviral drugs is critical for heavily treatment-experienced patients living with multidrug resistant...
Conference Coverage
HIV does not appear to worsen COVID-19 outcomes
“We don’t see any signs that people with HIV should take extra precautions” to protect themselves from COVID-19, said Keith Sigel, MD.
News
Higher stroke rates seen among patients with COVID-19 compared with influenza
Clinicians should be vigilant for symptoms and signs of acute ischemic stroke in patients with COVID-19.
News
Sepsis readmissions risk linked to residence in a poor neighborhoods
Patients who live in disadvantaged neighborhoods may not have access to healthy food and safe housing.